Jubilant Life Sciences reported net loss of Rs 137.02 crore in the quarter ended December 2011 as against net profit of Rs 71.42 crore during the previous quarter ended December 2010. Sales rose 16.38% to Rs 674.51 crore in the quarter ended December 2011 as against Rs 579.57 crore during the previous quarter ended December 2010.
In the consolidated results, the company reported net loss after minority interest of Rs 78.39 crore in the quarter ended December 2011 as against net profit after minority interest of Rs 44.11 crore during the previous quarter ended December 2010. Sales reported to Rs 1087.17 crore in the quarter ended December 2011 as against Rs 866.47 crore during the previous quarter ended December 2010.
| Particulars | Quarter Ended |
| | Dec. 2011 | Dec. 2010 | % Var. |
| Sales | 674.51 | 579.57 | 16 |
| OPM % | 16.31 | 18.78 | -13 |
| PBDT | 69.75 | 94.67 | -26 |
| PBT | 37.47 | 69.41 | -46 |
| NP | -137.02 | 71.42 | PL |